Sperm Is a Focus of Start-Ups Looking to Boost Fertility
By Fiorella Valdesolo,
WSJ Magazine
| 06. 08. 2022
“Where is the we?” It’s the question that was the driving force for Vida Delrahim and Ronit Menashe when they created WeNatal, a new brand of prenatal supplements that aims to be more inclusive. In the process of trying to conceive, couples often use the word we. We’re trying to get pregnant. We’re having trouble conceiving. We’re having a baby. But, as Delrahim and Menashe realized after their own individual struggles to conceive, despite all the we, much of the burden of fertility optimization continues to fall on women. It’s an imbalance that WeNatal and a number of other start-ups are starting to address.
In the quest for high-quality embryos and viable pregnancies, sperm is critical, says Toronto-based reproductive endocrinologist Dan Nayot, who is chief medical advisor for fertility supplement company Bird&Be. And good sperm is about both quality and quantity. In a routine semen analysis, Nayot generally looks at the volume of semen (a combination of seminal fluid and sperm); sperm concentration (how many millions of sperm per millimeter); sperm motility (how many are actually moving...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...